CGRPs for Migraine Tied to ‘Modest’ Heart Risk

by | Feb 3, 2026 | Health

Spread the love
Initiation of calcitonin gene-related peptide inhibitors for migraine is linked to a small increased risk for a composite of cardiovascular events, a new study shows.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments